
Daniel Kulp, Ph.D.
Laboratory
The Kulp Laboratory
Contact
Associate Professor, Vaccine & Immunotherapy Center
About the Scientist
Kulp has more than 15 years of experience developing molecular design software and leading protein engineering projects. He joined Wistar from The Scripps Research Institute and International AIDS Vaccine Initiative where he was a principal scientist.
Kulp received a bachelor’s degree in Computer Science and Molecular Biology & Biochemistry from Rutgers, The State University of New Jersey, followed by a Ph.D. in Biochemistry and Molecular Biophysics from the University of Pennsylvania. He completed postdoctoral training in structure-based and experimental protein engineering at Los Alamos National Laboratory.
Lab in the News
The Kulp Laboratory
The Kulp laboratory focuses on rational vaccine and therapeutic antibody design for a variety of priority infectious diseases (e.g. Lassa Virus, HIV, Influenza) and cancer targets. The ultimate test of the lab's understanding of B cell immune responses is to design new immunogens that drive predictable antibody maturation. To that end, the lab is interested in the development and application of protein engineering methods for modifying antigen/cell receptor interfaces, antigen/antibody interfaces, antigen surface properties and core stabilization.
Staff Listing
PI
Daniel Kulp, Ph.D.
Postdoctoral Fellow
Jinwei Huang
PhD Graduate Students
Michaela Helble
Kylie Konrath
Rumi Habib
Niklas Laegner
Shahlo Solieva
Yuanhan Wu
MS Graduate Student
Sarah Kim
Research Assistants
Kelly Bayruns
Amber Kim
Joyce Park
Madison McCanna
Research Apprentice
Alex Dalton
Lab Alumni
Susanne Walker - Merck
Neethu Chokkalingkam – Ocugen
Sinja Kriete – Lake Erie College of Osteopathic Medicine (DO student)
Nicholas Shupin - Robert Wood Johnson Medical School (MD student)
Alana Hyunh – University of Rochester (PhD student)
Published on
Published on
Published on
Published on
Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity
Published on
In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity
Published on
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
Published on
Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination
Published on